Molekule Group Stock Current Asset
Molekule Group fundamentals help investors to digest information that contributes to Molekule's financial success or failures. It also enables traders to predict the movement of Molekule Stock. The fundamental analysis module provides a way to measure Molekule's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molekule stock.
Molekule |
Molekule Group Company Current Asset Analysis
Molekule's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Molekule Group has a Current Asset of 0.0. This is 100.0% lower than that of the Machinery sector and 100.0% lower than that of the Industrials industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Molekule Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molekule's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molekule could also be used in its relative valuation, which is a method of valuing Molekule by comparing valuation metrics of similar companies.Molekule is currently under evaluation in current asset category among its peers.
Molekule Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.47) % | |||
| Current Valuation | 45.01 M | |||
| Shares Outstanding | 34.65 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 30.70 % | |||
| Number Of Shares Shorted | 775.6 K | |||
| Revenue | 48.03 M | |||
| Gross Profit | 277.62 K | |||
| EBITDA | 8.34 M | |||
| Net Income | (1.55 M) | |||
| Total Debt | 46.72 M | |||
| Book Value Per Share | 1.20 X | |||
| Cash Flow From Operations | (41.28 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (0.68) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 91 | |||
| Market Capitalization | 1.87 M | |||
| Total Asset | 52.32 M | |||
| Retained Earnings | (7.92 M) | |||
| Working Capital | 20.22 M | |||
| Z Score | 1.72 | |||
| Net Asset | 52.32 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |